A
Apontis Pharma AG
XETRA:APPH
Apontis Pharma AG
XETRA:APPH
Price:
11
EUR
Market Cap:
€93.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apontis Pharma AG
XETRA:APPH
|
DE |
|
Location Based Technologies Inc
OTC:LBAS
|
US |
Multiples-Based Value
The Multiples-Based Value of one APPH stock under the Base Case scenario is 10.42 EUR. Compared to the current market price of 11 EUR, Apontis Pharma AG is Overvalued by 5%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APPH
Multiples-Based Value
Base Case
10.42
EUR
Overvaluation 5%
A
Multiples Across Competitors
APPH Competitors Multiples
Apontis Pharma AG Competitors
Apontis Pharma AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
A
|
Apontis Pharma AG
XETRA:APPH
|
91.6m EUR | 1.4 | 122.2 | 22.7 | 84.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.8 | 43.7 | 29.5 | 31.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.7 | 16.9 | 23.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.7 | 16.6 | 10.3 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.5B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
